See also this year's filing and all EDGAR filings for this company.
PDF Report 0001737523_2024_Bionexus_Gene_Lab_Corp.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Liabilities', 'missing_ratio': 0.05991389987582024, 'aggregate_val': 1741941, 'exp_sum': 1852959, 'exp_to_value': {'LongTermLiabilities': 111018, 'LiabilitiesCurrent': 1643178, 'remainder_Liabilities': 98763}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.22727863062610681, 'aggregate_val': 11399793, 'exp_sum': 14752786, 'exp_to_value': {'IntangibleAssets': 0, 'AssetsNonCurrent': 3352993, 'AssetsCurrent': 8046800, 'PropertyPlantAndEquipment': 1511618, 'remainder_Assets': 1841375}} |
Graph
Absolute values for 0001737523, Bionexus Gene Lab Corp
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 3,352,993 |
| 2 | AssetsCurrent | 8,046,800 |
| 3 | PropertyPlantAndEquipment | 1,511,618 |
| 4 | remainder_Assets | -1,511,618 |
| 5 | LongTermLiabilities | 111,018 |
| 6 | LiabilitiesCurrent | 1,643,178 |
| 7 | remainder_Liabilities | -12,255 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 8,441,308 |
| 10 | GeneralAndAdministrativeExpense | 4,409,122 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -21,526 |
| 17 | remainder_Revenues | 10,256,842 |
| 18 | remainder_NetIncome | -13,929 |
| 19 | remainder_ComprehensiveNetIncome | -268,232 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 11,399,793 |
| 1 | Liabilities | 1,741,941 |
| 2 | Expenses | 12,828,904 |
| 3 | Revenues | 10,256,842 |
| 4 | StockholdersEquity | 9,657,852 |
| 5 | NetIncome | -2,585,991 |
| 6 | ComprehensiveNetIncome | -2,854,223 |
| 7 | BaseVar | 18,254,820 |
| 8 | EconomicCapitalRatio | 3.65 |